Admin Core
Admin Core
批准号:
10592381
负责人:
David R Andes
金额:
$31.48万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-04-01 至 2025-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Antimicrobial innovation has slowed to a crawl while an epidemic of antimicrobial-resistant infections surges,
threatening the public health. The overarching goal of the Wisconsin Antimicrobial Drug Discovery and
Development Center is to develop therapeutic countermeasures to tackle the antimicrobial resistance crisis.
Based upon our preliminary data, we hypothesize that natural product exploration of symbiotic environments
using complementary cutting-edge approaches will provide a new paradigm for discovery of novel
antimicrobials targeting drug resistant infections. The Center proposes innovative conceptual and technical
advances to overcome critical bottlenecks identified in traditional antimicrobial drug discovery platforms. The
success of this endeavor hinges upon the cohesive efforts from a diverse group of scientists and technical
resources. The Administrative Core will be directed by Andes and advised by an Internal and External Advisory
Board comprised of experts in infectious diseases, antimicrobial resistance, drug discovery and development,
natural products, and technology transfer and licensing. Additionally, it will include an administrator with
extensive experience in research and business administration, and prior oversight of NIH funded program
projects and centers. The overall goals of the administrative core are to provide leadership and the
organizational back bone for this proposal, promote collaboration between the Projects and Cores, and
coordinate its interaction with NIAID staff.
/Relevance/
There are no effective therapies for the emerging resistant pathogens that are becoming an increasing threat
to the public health. The goals of the Center are to provide new, broad spectrum antimicrobial agents through
a collaborative focus on high value natural product leads produced by under-explored sources of biological
diversity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Symbiotic-based discovery of turbinmicin, a safe and selective antifungal against resistant fungi
-
批准号:10584574
-
项目类别:
-
资助金额:$71.0万
-
财政年份:2022
-
负责人:David R Andes
-
依托单位:
Symbiotic-based discovery of turbinmicin, a safe and selective antifungal against resistant fungi
-
批准号:10414553
-
项目类别:
-
资助金额:$77.75万
-
财政年份:2022
-
负责人:David R Andes
-
依托单位:
Molecular Mycology: Current Approaches to Fungal Pathogenesis (MoMy) Training Course
-
批准号:10461947
-
项目类别:
-
资助金额:$10.81万
-
财政年份:2021
-
负责人:David R Andes
-
依托单位:
Molecular Mycology: Current Approaches to Fungal Pathogenesis (MoMy) Training Course
-
批准号:10313447
-
项目类别:
-
资助金额:$10.81万
-
财政年份:2021
-
负责人:David R Andes
-
依托单位:
Molecular Mycology: Current Approaches to Fungal Pathogenesis (MoMy) Training Course
-
批准号:10664997
-
项目类别:
-
资助金额:$10.81万
-
财政年份:2021
-
负责人:David R Andes
-
依托单位:
Novel antimicrobials targeting MDR pathogens from animal microbial symbionts
-
批准号:10376275
-
项目类别:
-
资助金额:$597.77万
-
财政年份:2019
-
负责人:David R Andes
-
依托单位:
In vivo Core
-
批准号:10592383
-
项目类别:
-
资助金额:$63.48万
-
财政年份:2019
-
负责人:David R Andes
-
依托单位:
Novel antimicrobials targeting MDR pathogens from animal microbial symbionts
-
批准号:10592380
-
项目类别:
-
资助金额:$595.5万
-
财政年份:2019
-
负责人:David R Andes
-
依托单位:
In vivo Core
-
批准号:10571216
-
项目类别:
-
资助金额:$51.5万
-
财政年份:2019
-
负责人:David R Andes
-
依托单位:
Admin Core
-
批准号:10571214
-
项目类别:
-
资助金额:$76.35万
-
财政年份:2019
-
负责人:David R Andes
-
依托单位:
Development of non-toxic amphotericin B derivatives targeting invasive fungal infections
-
批准号:10405641
-
项目类别:
-
资助金额:$70.23万
-
财政年份:2018
-
负责人:David R Andes
-
依托单位:
Development of non-toxic amphotericin B derivatives targeting invasive fungal infections
-
批准号:10183149
-
项目类别:
-
资助金额:$71.44万
-
财政年份:2018
-
负责人:David R Andes
-
依托单位:
Antibiotic targeting of protein interfaces in bacterial genome maintenance comple
-
批准号:8803320
-
项目类别:
-
资助金额:$18.41万
-
财政年份:2014
-
负责人:David R Andes
-
依托单位:
Antimicrobial Drug Discovery from Coevolved Symbiotic Communities
-
批准号:9235217
-
项目类别:
-
资助金额:$319.01万
-
财政年份:2014
-
负责人:David R Andes
-
依托单位:
Antimicrobial Drug Discovery from Coevolved Symbiotic Communities
-
批准号:8641509
-
项目类别:
-
资助金额:$343.33万
-
财政年份:2014
-
负责人:David R Andes
-
依托单位:
Antibiotic targeting of protein interfaces in bacterial genome maintenance comple
-
批准号:8703312
-
项目类别:
-
资助金额:$22.17万
-
财政年份:2014
-
负责人:David R Andes
-
依托单位:
Antimicrobial Drug Discovery from Coevolved Symbiotic Communities
-
批准号:9014482
-
项目类别:
-
资助金额:$319.01万
-
财政年份:2014
-
负责人:David R Andes
-
依托单位:
FLUCONAZOLE-BIOFILM MATRIX IN CANDIDA ALBICANS
-
批准号:8168970
-
项目类别:
-
资助金额:$0.01万
-
财政年份:2010
-
负责人:David R Andes
-
依托单位:
TRAINING IN THE USE OF BRUKER AND VARIAN SPECTROMETERS AND NMR
-
批准号:8168976
-
项目类别:
-
资助金额:$0.01万
-
财政年份:2010
-
负责人:David R Andes
-
依托单位:
Antifungal Resistance Mechanism in Biofilm Growing candida albicans
-
批准号:7636802
-
项目类别:
-
资助金额:$36.74万
-
财政年份:2008
-
负责人:David R Andes
-
依托单位:
国内基金
海外基金
登录
查看更多内容
胆固醇羟化酶CH25H非酶活依赖性促进乙型肝炎病毒蛋白Core及Pre-core降解的分子机制研究
-
批准号:82371765
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:谭广云
-
依托单位:
锕系元素5f-in-core的GTH赝势和基组的开发
-
批准号:22303037
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:鲁俊波
-
依托单位:
基于合成致死策略搭建Core-matched前药共组装体克服肿瘤耐药的机制研究
-
批准号:--
-
项目类别:--
-
资助金额:52万元
-
批准年份:2022
-
负责人:孙丙军
-
依托单位:
鼠伤寒沙门氏菌LPS core经由CD209/SphK1促进树突状细胞迁移加重炎症性肠病的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:叶成林
-
依托单位:
基于外泌体精准调控的“核-壳”(core-shell)同步血管化骨组织工程策略的应用与机制探讨
-
批准号:--
-
项目类别:--
-
资助金额:55万元
-
批准年份:2020
-
负责人:张智勇
-
依托单位:
基于外泌体精准调控的“核-壳”(core-shell)同步血管化骨组织工程策略的应用与机制探讨
-
批准号:82072415
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:张智勇
-
依托单位:
肌营养不良蛋白聚糖Core M3型甘露糖肽的精确制备及功能探索
-
批准号:92053110
-
项目类别:重大研究计划
-
资助金额:70.0万元
-
批准年份:2020
-
负责人:彭鹏
-
依托单位:
Core-1-O型聚糖黏蛋白缺陷诱导胃炎发生并介导慢性胃炎向胃癌转化的分子机制研究
-
批准号:81902805
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:刘菲
-
依托单位:
原始地球增生晚期的Core-merging大碰撞事件:地核增生、核幔平衡与核幔边界结构的新认识
-
批准号:41973063
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2019
-
负责人:周游
-
依托单位:
CORDEX-CORE区域气候模拟与预估研讨会
-
批准号:41981240365
-
项目类别:国际(地区)合作与交流项目
-
资助金额:1.5万元
-
批准年份:2019
-
负责人:陈威霖
-
依托单位: